-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TsnndpXnfTsVMFWXjjDTTaiMM/bV4kW0XYCvg9ms+1CsWaFBr6LV2nBWDTBXIJhM ULVErtHn3CIzy15T0G2abA== 0001209191-05-001847.txt : 20050105 0001209191-05-001847.hdr.sgml : 20050105 20050105171307 ACCESSION NUMBER: 0001209191-05-001847 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050103 FILED AS OF DATE: 20050105 DATE AS OF CHANGE: 20050105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SIMON ROBERT L CENTRAL INDEX KEY: 0001220050 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15190 FILM NUMBER: 05513523 MAIL ADDRESS: STREET 1: 58 S SERVICE RD CITY: MELVILLE STATE: NY ZIP: 11747 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSI PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000729922 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133159796 STATE OF INCORPORATION: DE FISCAL YEAR END: 1204 BUSINESS ADDRESS: STREET 1: 58 SOUTH SERVICE RD. STREET 2: SUITE 110 CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: 631-962-2000 MAIL ADDRESS: STREET 1: 58 SOUTH SERVICE RD. STREET 2: SUITE 110 CITY: MELVILLE STATE: NY ZIP: 11747 FORMER COMPANY: FORMER CONFORMED NAME: ONCOGENE SCIENCE INC DATE OF NAME CHANGE: 19920703 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2005-01-03 0 0000729922 OSI PHARMACEUTICALS INC OSIP 0001220050 SIMON ROBERT L C/O OSI PHARMACEUTICALS, INC. 58 SOUTH SERVICE ROAD, SUITE 110 MELVILLE NY 11747 0 1 0 0 VP, Global Reg. Affairs & CMC Common Stock 2005-01-03 4 M 0 1500 45.01 A 5800 D Common Stock 2005-01-03 4 M 0 3500 21.55 A 9300 D Common Stock 2005-01-03 4 S 0 850 72.15 D 8450 D Common Stock 2005-01-03 4 S 0 200 72.17 D 8250 D Common Stock 2005-01-03 4 S 0 200 72.18 D 8050 D Common Stock 2005-01-03 4 S 0 395 73.52 D 7655 D Common Stock 2005-01-03 4 S 0 896 73.53 D 6859 D Common Stock 2005-01-03 4 S 0 26 73.60 D 6733 D Common Stock 2005-01-03 4 S 0 9 73.62 D 6724 D Common Stock 2005-01-03 4 S 0 438 73.65 D 6286 D Common Stock 2005-01-03 4 S 0 219 73.95 D 6067 D Common Stock 2005-01-03 4 S 0 70 74.05 D 5997 D Common Stock 2005-01-03 4 S 0 18 74.10 D 5979 D Common Stock 2005-01-03 4 S 0 9 74.17 D 5970 D Common Stock 2005-01-03 4 S 0 53 74.40 D 5917 D Common Stock 2005-01-03 4 S 0 43 74.41 D 5874 D Common Stock 2005-01-03 4 S 0 61 74.42 D 5813 D Common Stock 2005-01-03 4 S 0 8 74.43 D 5805 D Common Stock 2005-01-03 4 S 0 1149 74.47 D 4656 D Common Stock 2005-01-03 4 S 0 88 74.50 D 4568 D Common Stock 2005-01-03 4 S 0 18 74.60 D 4550 D Stock Option (Right to Buy) 45.01 2005-01-03 4 M 0 1500 0.00 D 2003-01-02 2012-01-01 Common Stock 1500 44000 D Stock Option (Right to Buy) 21.55 2005-01-03 4 M 0 3500 0.00 D 2003-06-12 2012-06-11 Common Stock 3500 13800 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. One third of the stock option became exercisable one year after the date of the grant and the remainder vested ratably on a monthly basis over the succeeding 24 months. The stock option was granted pursuant to one of the Issuer's incentive and non-qualified stock option plans and is exempt under Rule 16b-3. Includes only options with the same termination date. Robert L. Van Nostrand by Power of Attorney 2005-01-05 -----END PRIVACY-ENHANCED MESSAGE-----